Nucleic acid biomarkers of β cell stress and death in type 1 diabetes

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Purpose of review The purpose of this review is to summarize recent advances in the development of nucleic acid-based biomarkers of type 1 diabetes (T1D). Recent findings Recent rodent and human studies have identified new roles for stress pathways intrinsic to the β cell during the development of T1D. As such, methods to identify an authentic nucleic acid signature of β cell stress and/or death may improve our ability to predict T1D at earlier timepoints, allowing for optimal timing of immunomodulatory interventions. To this end, both targeted and unbiased approaches have begun to identify changes in microRNA expression patterns in T1D. Moreover, a number of groups have developed distinct assays that quantitatively detect circulating unmethylated insulin DNA, which is thought to primarily emanate from dying β cells. Summary Here we highlight unique blood and urine microRNA signatures identified in T1D cohorts, compare differences between first, second, and third-generation assays that detect circulating unmethylated insulin DNA, and review recent technological advances that have the capacity to improve T1D biomarker development.

Original languageEnglish (US)
Pages (from-to)312-317
Number of pages6
JournalCurrent Opinion in Endocrinology, Diabetes and Obesity
Volume23
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Type 1 Diabetes Mellitus
Nucleic Acids
Cell Death
Biomarkers
MicroRNAs
Insulin
DNA
Rodentia
Urine

Keywords

  • biomarkers
  • cell-free insulin DNA
  • miRNA
  • type 1 diabetes
  • unmethylated insulin DNA

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Cite this

Nucleic acid biomarkers of β cell stress and death in type 1 diabetes. / Syed, Farooq; Evans-Molina, Carmella.

In: Current Opinion in Endocrinology, Diabetes and Obesity, Vol. 23, No. 4, 01.08.2016, p. 312-317.

Research output: Contribution to journalReview article

@article{a85f6c9bd13545e9885e1489bdbce4f3,
title = "Nucleic acid biomarkers of β cell stress and death in type 1 diabetes",
abstract = "Purpose of review The purpose of this review is to summarize recent advances in the development of nucleic acid-based biomarkers of type 1 diabetes (T1D). Recent findings Recent rodent and human studies have identified new roles for stress pathways intrinsic to the β cell during the development of T1D. As such, methods to identify an authentic nucleic acid signature of β cell stress and/or death may improve our ability to predict T1D at earlier timepoints, allowing for optimal timing of immunomodulatory interventions. To this end, both targeted and unbiased approaches have begun to identify changes in microRNA expression patterns in T1D. Moreover, a number of groups have developed distinct assays that quantitatively detect circulating unmethylated insulin DNA, which is thought to primarily emanate from dying β cells. Summary Here we highlight unique blood and urine microRNA signatures identified in T1D cohorts, compare differences between first, second, and third-generation assays that detect circulating unmethylated insulin DNA, and review recent technological advances that have the capacity to improve T1D biomarker development.",
keywords = "biomarkers, cell-free insulin DNA, miRNA, type 1 diabetes, unmethylated insulin DNA",
author = "Farooq Syed and Carmella Evans-Molina",
year = "2016",
month = "8",
day = "1",
doi = "10.1097/MED.0000000000000261",
language = "English (US)",
volume = "23",
pages = "312--317",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Nucleic acid biomarkers of β cell stress and death in type 1 diabetes

AU - Syed, Farooq

AU - Evans-Molina, Carmella

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Purpose of review The purpose of this review is to summarize recent advances in the development of nucleic acid-based biomarkers of type 1 diabetes (T1D). Recent findings Recent rodent and human studies have identified new roles for stress pathways intrinsic to the β cell during the development of T1D. As such, methods to identify an authentic nucleic acid signature of β cell stress and/or death may improve our ability to predict T1D at earlier timepoints, allowing for optimal timing of immunomodulatory interventions. To this end, both targeted and unbiased approaches have begun to identify changes in microRNA expression patterns in T1D. Moreover, a number of groups have developed distinct assays that quantitatively detect circulating unmethylated insulin DNA, which is thought to primarily emanate from dying β cells. Summary Here we highlight unique blood and urine microRNA signatures identified in T1D cohorts, compare differences between first, second, and third-generation assays that detect circulating unmethylated insulin DNA, and review recent technological advances that have the capacity to improve T1D biomarker development.

AB - Purpose of review The purpose of this review is to summarize recent advances in the development of nucleic acid-based biomarkers of type 1 diabetes (T1D). Recent findings Recent rodent and human studies have identified new roles for stress pathways intrinsic to the β cell during the development of T1D. As such, methods to identify an authentic nucleic acid signature of β cell stress and/or death may improve our ability to predict T1D at earlier timepoints, allowing for optimal timing of immunomodulatory interventions. To this end, both targeted and unbiased approaches have begun to identify changes in microRNA expression patterns in T1D. Moreover, a number of groups have developed distinct assays that quantitatively detect circulating unmethylated insulin DNA, which is thought to primarily emanate from dying β cells. Summary Here we highlight unique blood and urine microRNA signatures identified in T1D cohorts, compare differences between first, second, and third-generation assays that detect circulating unmethylated insulin DNA, and review recent technological advances that have the capacity to improve T1D biomarker development.

KW - biomarkers

KW - cell-free insulin DNA

KW - miRNA

KW - type 1 diabetes

KW - unmethylated insulin DNA

UR - http://www.scopus.com/inward/record.url?scp=84976633762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976633762&partnerID=8YFLogxK

U2 - 10.1097/MED.0000000000000261

DO - 10.1097/MED.0000000000000261

M3 - Review article

VL - 23

SP - 312

EP - 317

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 4

ER -